Overview
The aim of this study is to determine the clinical spectrum and natural progression of Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL) and related disorders in a prospective multicenter study, to assess the clinical, genetic and epigenetic features of patients with CADASIL , to optimize clinical management.
Eligibility
Inclusion Criteria:
- Sign informed consent.
- Age>18
- Clinical diagnosis of patients with CADASIL,and confirmed by genetic test or skin biopsy
- Asymptomatic NOTCH3 mutation carriers
- Relatives of CADASIL patients or carriers
- Unrelated healthy controls
Exclusion Criteria:
- Unable to cooperate with inspectors
- Serious systemic illness, such as heart, liver, kidney disease or major mental illness
- Contraindications for imaging examination